These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 39008959)

  • 1. Impact of Renin-Angiotensin System Blockade on Mortality and Allograft Loss among Renal Transplant Recipients: A Systematic Review and Meta-Analysis.
    Kung CW; Lin YC; Tseng CS; Chou YH
    Nephron; 2024 Jul; ():1-11. PubMed ID: 39008959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials.
    Hiremath S; Fergusson DA; Fergusson N; Bennett A; Knoll GA
    Am J Kidney Dis; 2017 Jan; 69(1):78-86. PubMed ID: 27712852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Renin-angiotensin System Inhibitors on Kidney Allograft Survival: A Systematic Review and Meta-analysis.
    Cheungpasitporn W; Thongprayoon C; Mao MA; Kittanamongkolchai W; Sathick IJ; Erickson SB
    N Am J Med Sci; 2016 Jul; 8(7):291-6. PubMed ID: 27583237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of renin-angiotensin system inhibitors on survival in kidney transplant recipients: A systematic review and meta-analysis.
    Jiang YM; Song TR; Qiu Y; Liu JP; Wang XD; Huang ZL; Lin T
    Kaohsiung J Med Sci; 2018 Jan; 34(1):1-13. PubMed ID: 29310811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD).
    Shin JI; Palta M; Djamali A; Kaufman DB; Astor BC
    Transplantation; 2016 Jul; 100(7):1541-9. PubMed ID: 26566058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Cooper TE; Teng C; Tunnicliffe DJ; Cashmore BA; Strippoli GF
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007751. PubMed ID: 37466151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis.
    Pisano A; Bolignano D; Mallamaci F; D'Arrigo G; Halimi JM; Persu A; Wuerzner G; Sarafidis P; Watschinger B; Burnier M; Zoccali C
    Nephrol Dial Transplant; 2020 May; 35(5):878-887. PubMed ID: 31143926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
    Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risks of dual blockade of the renin-angiotensin system compared with monotherapy: a systematic review and cumulative meta-analysis of randomized trials and observational studies].
    Catalá-López F; Macías Saint-Gerons D; de la Fuente Honrubia C; Martín-Serrano G
    Rev Esp Salud Publica; 2014; 88(1):37-65. PubMed ID: 24728391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renin angiotensin system blockade in kidney transplantation: pros and cons.
    Cruzado JM; Rico J; Grinyó JM
    Transpl Int; 2008 Apr; 21(4):304-13. PubMed ID: 18266774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of SGLT2 inhibitors combining with renin-angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis.
    Liu T; Li R; Wang X; Gao X; Zhang X
    Med Clin (Barc); 2022 Jul; 159(2):65-72. PubMed ID: 34872768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Renal Transplant Recipients.
    Zakrzewska A; Tylicki L; Debska-Slizien A
    Transplant Proc; 2018; 50(6):1834-1837. PubMed ID: 30056910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension.
    Wang GM; Li LJ; Tang WL; Wright JM
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012569. PubMed ID: 33089502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive treatment for kidney transplant recipients.
    Natale P; Mooi PK; Palmer SC; Cross NB; Cooper TE; Webster AC; Masson P; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2024 Jul; 7(7):CD003598. PubMed ID: 39082471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-immunosuppressive treatment for IgA nephropathy.
    Tunnicliffe DJ; Reid S; Craig JC; Samuels JA; Molony DA; Strippoli GF
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD003962. PubMed ID: 38299639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.